These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 27855620

  • 1. MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion.
    Lorendeau D, Dury L, Nasr R, Boumendjel A, Teodori E, Gutschow M, Falson P, Di Pietro A, Baubichon-Cortay H.
    Curr Med Chem; 2017; 24(12):1186-1213. PubMed ID: 27855620
    [Abstract] [Full Text] [Related]

  • 2. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S, Khonkarn R, Moreno A, Baubichon-Cortay H, Miri R, Khoshneviszadeh M, Saso L, Edraki N, Falson P, Firuzi O.
    Toxicol Appl Pharmacol; 2019 Jan 01; 362():136-149. PubMed ID: 30391378
    [Abstract] [Full Text] [Related]

  • 3. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
    Lorendeau D, Dury L, Genoux-Bastide E, Lecerf-Schmidt F, Simões-Pires C, Carrupt PA, Terreux R, Magnard S, Di Pietro A, Boumendjel A, Baubichon-Cortay H.
    Biochem Pharmacol; 2014 Aug 01; 90(3):235-45. PubMed ID: 24875445
    [Abstract] [Full Text] [Related]

  • 4. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW, Wu X, Yin C, Chai S, Yao S, Kadioglu O, Efferth T, Ye Y, Lin G.
    J Ethnopharmacol; 2017 May 05; 203():110-119. PubMed ID: 28363522
    [Abstract] [Full Text] [Related]

  • 5. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV.
    Mol Cell Biochem; 2007 Feb 05; 296(1-2):85-95. PubMed ID: 16960658
    [Abstract] [Full Text] [Related]

  • 6. MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor.
    Riganti C, Giampietro R, Kopecka J, Costamagna C, Abatematteo FS, Contino M, Abate C.
    Int J Mol Sci; 2020 May 08; 21(9):. PubMed ID: 32397184
    [Abstract] [Full Text] [Related]

  • 7. Relevance of multidrug resistance in the age of targeted therapy.
    Türk D, Szakács G.
    Curr Opin Drug Discov Devel; 2009 Mar 08; 12(2):246-52. PubMed ID: 19333870
    [Abstract] [Full Text] [Related]

  • 8. Ferrocene-embedded flavonoids targeting the Achilles heel of multidrug-resistant cancer cells through collateral sensitivity.
    Pérès B, Nasr R, Zarioh M, Lecerf-Schmidt F, Di Pietro A, Baubichon-Cortay H, Boumendjel A.
    Eur J Med Chem; 2017 Apr 21; 130():346-353. PubMed ID: 28273561
    [Abstract] [Full Text] [Related]

  • 9. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
    Mohammad IS, He W, Yin L.
    Biomed Pharmacother; 2018 Apr 21; 100():335-348. PubMed ID: 29453043
    [Abstract] [Full Text] [Related]

  • 10. Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition.
    Hanssen KM, Haber M, Fletcher JI.
    Drug Resist Updat; 2021 Dec 21; 59():100795. PubMed ID: 34983733
    [Abstract] [Full Text] [Related]

  • 11. Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity.
    Teodori E, Dei S, Floriddia E, Perrone MG, Manetti D, Romanelli MN, Contino M, Colabufo NA.
    ChemMedChem; 2015 Aug 21; 10(8):1339-43. PubMed ID: 26012726
    [Abstract] [Full Text] [Related]

  • 12. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC, Sun YL, Salim AA, Chen ZS, Capon RJ.
    Biochem Pharmacol; 2013 May 01; 85(9):1257-68. PubMed ID: 23415901
    [Abstract] [Full Text] [Related]

  • 13. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F, Lu P, Cortés-Selva F, Pérez-Victoria JM, Jiménez IA, Ravelo AG, Sharom FJ, Gamarro F, Castanys S.
    Cancer Res; 2004 Oct 01; 64(19):7130-8. PubMed ID: 15466210
    [Abstract] [Full Text] [Related]

  • 14. 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity.
    Rocha Gda G, Oliveira RR, Kaplan MA, Gattass CR.
    Eur J Pharmacol; 2014 Oct 15; 741():140-9. PubMed ID: 25111243
    [Abstract] [Full Text] [Related]

  • 15. Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins.
    Diah SK, Smitherman PK, Aldridge J, Volk EL, Schneider E, Townsend AJ, Morrow CS.
    Cancer Res; 2001 Jul 15; 61(14):5461-7. PubMed ID: 11454692
    [Abstract] [Full Text] [Related]

  • 16. Curcumin as chemosensitizer.
    Limtrakul P.
    Adv Exp Med Biol; 2007 Jul 15; 595():269-300. PubMed ID: 17569216
    [Abstract] [Full Text] [Related]

  • 17. Microparticles and their emerging role in cancer multidrug resistance.
    Gong J, Jaiswal R, Mathys JM, Combes V, Grau GE, Bebawy M.
    Cancer Treat Rev; 2012 May 15; 38(3):226-34. PubMed ID: 21757296
    [Abstract] [Full Text] [Related]

  • 18. Monoterpene indole alkaloid azine derivatives as MDR reversal agents.
    Paterna A, Khonkarn R, Mulhovo S, Moreno A, Madeira Girio P, Baubichon-Cortay H, Falson P, Ferreira MU.
    Bioorg Med Chem; 2018 Jan 15; 26(2):421-434. PubMed ID: 29233614
    [Abstract] [Full Text] [Related]

  • 19. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL, Liang YJ, Wang YS, Tiwari AK, Yan YY, Wang F, Chen ZS, Tong XZ, Fu LW.
    Cancer Lett; 2009 Jun 28; 279(1):74-83. PubMed ID: 19232821
    [Abstract] [Full Text] [Related]

  • 20. Flavonoid dimers are highly potent killers of multidrug resistant cancer cells overexpressing MRP1.
    Dury L, Nasr R, Lorendeau D, Comsa E, Wong I, Zhu X, Chan KF, Chan TH, Chow L, Falson P, Di Pietro A, Baubichon-Cortay H.
    Biochem Pharmacol; 2017 Jan 15; 124():10-18. PubMed ID: 27984000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.